SynopsisVYXEOS is a liposomal combination of daunorubicin, an anthracycline topoisomerase inhibitor, and cytarabine, The global Cytarabine and Daunorubicin Drugs market was valued at US$ 128 million in 2023 and is anticipated to reach US$ 184 million by 2030, wi.....
SynopsisVYXEOS is a liposomal combination of daunorubicin, an anthracycline topoisomerase inhibitor, and cytarabine, The global Vyxeos market was valued at US$ 128 million in 2023 and is anticipated to reach US$ 184 million by 2030, witnessing a CAGR of 5.3% dur.....
SynopsisAcute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia .....
SynopsisTrisenox is a chemotherapy drug and is also called Trisenox or ATO. It is a treatment for a type of acute myeloid leukaemia called acute promyelocytic leukaemia (APL). The global Trisenox market was valued at US$ 59 million in 2023 and is anticipated to.....
SynopsisArsenic trioxide is a chemotherapy drug and is also called Trisenox or ATO. It is a treatment for a type of acute myeloid leukaemia called acute promyelocytic leukaemia (APL). The global Arsenic Trioxide Drugs market was valued at US$ 59 million in 2023.....
SynopsisVesanoid is medication used for the treatment of acne and acute promyelocytic leukemia. For acne, it is applied to the skin as a cream or ointment. For leukemia, it is taken by mouth for up to three months. The global Vesanoid market was valued at US$ 27.....
SynopsisTretinoin is medication used for the treatment of acne and acute promyelocytic leukemia. For acne, it is applied to the skin as a cream or ointment. For leukemia, it is taken by mouth for up to three months. The global Tretinoin Drugs market was valued a.....
SynopsisPegademase bovine Injection is a modified enzyme used for enzyme replacement therapy for the treatment of severe combined immunodeficiency. The global Pegademase Bovine market was valued at US$ 79 million in 2023 and is anticipated to reach US$ 103.7 mil.....
SynopsisPegademase bovine Injection is a modified enzyme used for enzyme replacement therapy for the treatment of severe combined immunodeficiency. The global Pegademase Bovine Drugs market was valued at US$ 79 million in 2023 and is anticipated to reach US$ 103.....
SynopsisAdagen Injection is a modified enzyme used for enzyme replacement therapy for the treatment of severe combined immunodeficiency. The global Adagen market was valued at US$ 79 million in 2023 and is anticipated to reach US$ 103.7 million by 2030, witnessi.....
